Literature DB >> 12535076

Modified yeast cells to investigate the coupling of G protein-coupled receptors to specific G proteins.

Graham Ladds1, Kevin Davis, Edward W Hillhouse, John Davey.   

Abstract

G protein-coupled receptors (GPCRs) help to regulate the physiology of all the major organ systems. They respond to a multitude of ligands and activate a range of effector proteins to bring about the appropriate cellular response. The choice of effector is largely determined by the interaction of individual GPCRs with different G proteins. Several factors influence this interaction, and a better understanding of the process may enable a more rational approach to identifying compounds that affect particular signalling pathways. A number of systems have been developed for the analysis of GPCRs. All provide useful information, but the genetic amenability and relative simplicity of yeast makes them a particularly attractive option for ligand identification and pharmaceutical screening. Many, but not all, GPCRs are functional in the budding yeast Saccharomyces cerevisiae, and we have developed reporter strains of the fission yeast Schizosaccharomyces pombe as an alternative host. To provide a more generic system for investigating GPCRs, we created a series of yeast-human Galpha-transplants, in which the last five residues at the C-terminus of the yeast Galpha-subunit are replaced with the corresponding residues from different human G proteins. These enable GPCRs to be coupled to the Sz. pombe signalling machinery so that stimulation with an appropriate ligand induces the expression of a signal-dependent lacZ reporter gene. We demonstrate the specificity of the system using corticotropin releasing factor (CRF) and CRF-related peptides on two CRF receptors. We find that different combinations of ligand and receptor activate different Galpha-transplants, and the specificity of the coupling is similar to that in mammalian systems. Thus, CRF signalled through the Gs- and Gi-transplants, consistent with its regulation of adenylate cyclase, and was more active against the CRF-R1A receptor than against the CRF-R2B receptor. In contrast, urocortin II and urocortin III were selective for the CRF-R2B receptors. Furthermore, urocortin, but not CRF, induced signalling through the CRF-R1A receptor and the Gq-transplant. This is the first time that human GPCRs have been coupled to the signalling pathway in Sz. pombe, and the strains described in this study will complement the other systems available for studying this important family of receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535076     DOI: 10.1046/j.1365-2958.2003.03336.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  13 in total

1.  A physiologically required G protein-coupled receptor (GPCR)-regulator of G protein signaling (RGS) interaction that compartmentalizes RGS activity.

Authors:  Wayne Croft; Claire Hill; Eilish McCann; Michael Bond; Manuel Esparza-Franco; Jeannette Bennett; David Rand; John Davey; Graham Ladds
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

2.  Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.

Authors:  R T Hinkle; E Donnelly; D B Cody; M B Bauer; R J Sheldon; R J Isfort
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

3.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

Review 4.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

6.  Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast.

Authors:  C Weston; D Poyner; V Patel; S Dowell; G Ladds
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

7.  The role of the RACK1 ortholog Cpc2p in modulating pheromone-induced cell cycle arrest in fission yeast.

Authors:  Magdalena Mos; Manuel A Esparza-Franco; Emma L Godfrey; Kathryn Richardson; John Davey; Graham Ladds
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

8.  The Reporter System for GPCR Assay with the Fission Yeast Schizosaccharomyces pombe.

Authors:  Shintaro Sasuga; Toshiya Osada
Journal:  Scientifica (Cairo)       Date:  2012-12-31

9.  The coordination of cell growth during fission yeast mating requires Ras1-GTP hydrolysis.

Authors:  Cathryn Weston; Michael Bond; Wayne Croft; Graham Ladds
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

10.  Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors.

Authors:  Cathryn Weston; Ian Winfield; Matthew Harris; Rose Hodgson; Archna Shah; Simon J Dowell; Juan Carlos Mobarec; David A Woodlock; Christopher A Reynolds; David R Poyner; Harriet A Watkins; Graham Ladds
Journal:  J Biol Chem       Date:  2016-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.